Browse All

Current Filters

CLEAR FILTER x

TITLE

OCARINA II, Phase III Study: Results of Subcutaneous Ocrelizumab Administration in Patients with Multiple Sclerosis

Author:Newsome, Scott   Krzystanek, Ewa   Selmaj, Krzysztof   Goldstick, Lawrence   Figueiredo, Catarina   Townsend, Ben   Wolf, Christian   Zecevic, Dusanka   Giacobino, Caroline   Bortolami, Oscar   Shen, Yun-An   Kletzl, Heidemarie   Clinch, Susanne   Centonze, Diego   

Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making  

Topic:Multiple Sclerosis  

Program Number:S31.006  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD  School of Health Sciences in Katowice, Katowice, Poland  Centrum Neurologii, Lodz, Poland  University of Cincinnati, Cincinnati, OH  F. Hoffmann-La Roche Ltd., Basel, Switzerland  Lycalis sprl, Brussels, Belgium  Genentech, San Fransisco, CA  Tor Vergata University, Rome, Italy  

Safety and Efficacy of Frexalimab in Relapsing Multiple Sclerosis: 48-week Results from the Phase 2 Open-label Extension

Author:Giovannoni, Gavin   Granziera, Cristina   Mao-Draayer, Yang   Cutter, Gary   Kalbus, Oleksandr   Staikov, Ivan   Dufek, Michal   Saubadu, Stephane   Bejuit, Raphael   Djukic, Biljana   Truffinet, Philippe   Wallstroem, Erik   Vermersch, Patrick   

Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making  

Topic:Multiple Sclerosis  

Program Number:S31.007  

Author Institution:Queen Mary University of London, London, United Kingdom  University Hospital Basel and University of Basel, Basel, Switzerland  University of Michigan Medical Center, Ann Arbor, MI  University of Alabama at Birmingham (UAB) School of Public Health, Birmingham, AL  Dnipro State Medical University, Dnipro, Ukraine  Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria  St. Anne’s University Hospital, Brno, Czech Republic  Sanofi, Chilly Mazarin, France  Sanofi, Chilly-Mazarin, France  Sanofi, Cambridge, MA  Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France  

Digital Mobility Outcome Measures Are a Useful Phenotyping Tool in Multiple Sclerosis

Author:Brittain, Gavin   Buckley, Ellen   Leocani, Letizia   Martinis, Matteo   Dallas Costa, Gloria   Gassner, Heiko   Rothhammer, Veit   Stuerner, Klarissa   Becker, Clemens   Rochester, Lynn   Comi, Giancarlo   Sharrack, Basil   

Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making  

Topic:Multiple Sclerosis  

Program Number:S31.008  

Author Institution:Sheffield Teaching Hospitals NHS Trust and the University of Sheffield, Stockport, United Kingdom  University of Sheffield, Sheffield, United Kingdom  University Vita-Salute San Raffaele, INSPE, Milan, Italy  San Raffaele Hospital, Milan, Italy  University Hospital Erlangen, Erlangen, Germany  Universität Erlangen-Nuernberg, Erlangen, Germany  University Medical Center Schleswig Holstein, Kiel, Germany  Robert Bosch Hospital, Stuttgart, Germany  University of Newcastle upon Tyne, Newcastle Upon Tyne, United Kingdom  University Vita-Salute, Milan, Italy  

Comparative Effectiveness of Standard vs Extended Rituximab Dosing Intervals in Relapsing Remitting Multiple Sclerosis

Author:Langer-Gould, Annette   Smith, Jessica   Torres, Fernando   Li, Bonnie   

Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making  

Topic:Multiple Sclerosis  

Program Number:S31.009  

Author Institution:Southern California Permanente Medical Group, Los Angeles, CA  Southern California Permanente Medical Group, Pasadena, CA  

A Retrospective Analysis of Disease Modifying Drug Discontinuation in Patients with Multiple Sclerosis

Author:Karayi, Gnaneswari   Quinones-Herrero, Natalia   Martin, Janice   Chaudhry, Saima   Cahill, Jonathan   Rizvi, Syed   

Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making  

Topic:Multiple Sclerosis  

Program Number:S31.010  

Author Institution:Brown University, Providence, RI  The Warren Alpert Medical School of Brown University, Providence, RI  Brown Neurology , providence, RI